List of insiders holdings for INCYTE CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
14159 capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
Baker / Tisch Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
Baker Biotech Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2024-06-14 18:23:05 | 31,209,896 0 | 31,209,896 | Form 13D |
BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2024-10-02 16:11:45 | 559,963 28,217,048 | 28,777,011 | Form 4 |
BAKER BIOTECH CAPITAL II GP LLC BAKER FELIX BAKER JULIAN 10% Owner | 2009-03-02 17:05:36 | 18,593,196 0 | 18,593,196 | Form 13D |
TISCH ANDREW H No longer 10% owner. | 2005-02-10 11:31:03 | 1,541,669 0 | 1,541,669 | Form 13G |
TISCH THOMAS J No longer 10% owner. | 2004-08-13 15:58:35 | 117,592 1,416,661 | 1,534,253 | Form 4/A |
TISCH JAMES S No longer 10% owner. | 2004-08-13 15:58:06 | 117,592 1,216,661 | 1,334,253 | Form 4/A |
TISCH DANIEL R No longer 10% owner. | 2006-04-21 12:04:18 | 1,126,669 0 | 1,126,669 | Form 13G |
WHITFIELD ROY A Director | 2014-01-17 16:19:51 | 662,832 0 | 662,832 | Form 5 |
Hoppenot Herve Chairman / CEO | 2024-07-17 12:27:28 | 557,863 0 | 557,863 | Form 4 |
FRIEDMAN PAUL A Director | 2020-05-28 16:27:11 | 267,327 15,000 | 282,327 | Form 4 |
CAGNONI PABLO J President, R&D | 2024-07-17 12:28:04 | 265,581 0 | 265,581 | Form 4 |
BROOKE PAUL A Director | 2020-04-02 17:01:14 | 221,911 40,000 | 261,911 | Form 4 |
HASTINGS DAVID C Chief Financial Officer | 2014-06-06 18:47:53 | 227,470 0 | 227,470 | Form 4 |
Stamoulis Christiana EVP & Chief Financial Officer | 2024-07-17 12:25:00 | 123,324 0 | 123,324 | Form 4 |
Wenqing Yao EVP, Head of Discovery Chem | 2021-07-07 17:54:42 | 113,629 0 | 113,629 | Form 4 |
SWAIN PAULA J EVP, Human Resources | 2024-07-17 12:29:58 | 102,360 0 | 102,360 | Form 4 |
KELLER JOHN A Chief Business Officer | 2008-02-11 17:28:56 | 100,000 0 | 100,000 | Form 4 |
Andrews Patricia S Chief Commercial Officer | 2012-01-23 16:43:17 | 100,000 0 | 100,000 | Form 4 |
DE SCHUTTER RICHARD U Chairman | 2015-03-09 16:35:21 | 99,821 0 | 99,821 | Form 4 |
Stein Steven H EVP & Chief Medical Officer | 2024-08-14 15:37:17 | 90,011 0 | 90,011 | Form 4 |
Pasquale Maria E EVP & General Counsel | 2023-07-18 16:00:15 | 89,999 0 | 89,999 | Form 4 |
SAXE JON S Director | 2004-04-01 14:08:05 | 80,000 0 | 80,000 | Form 4 |
Dhanak Dashyant EVP & Chief Scientific Officer | 2023-07-18 16:00:18 | 75,864 0 | 75,864 | Form 4 |
Morrissey Michael James EVP, Head of Tech. Operations | 2024-01-24 14:15:13 | 72,300 0 | 72,300 | Form 4 |
Daly James M EVP, Chief Commercial Officer | 2015-06-25 16:28:05 | 71,283 0 | 71,283 | Form 4 |
METCALF BRIAN W Chief Drug Discovery Scientist | 2011-04-13 16:09:01 | 66,504 0 | 66,504 | Form 4 |
Flannelly Barry P EVP & General Manager US | 2024-11-08 12:48:59 | 58,042 0 | 58,042 | Form 4 |
ARIKO BARRY A Director | 2015-03-13 16:28:02 | 45,834 0 | 45,834 | Form 4 |
HURLEY SCOTT W VP/Corp Controller & Treasurer | 2005-01-27 12:58:59 | 40,000 0 | 40,000 | Form 4 |
Iyengar Vijay K EVP, GMAPPS | 2024-07-29 15:50:27 | 36,701 0 | 36,701 | Form 4 |
Dickinson Jonathan Elliott EVP, General Manager, Europe | 2024-09-16 13:24:17 | 36,390 0 | 36,390 | Form 4 |
Huber Reid M EVP, Chief Scientific Officer | 2018-07-18 16:28:26 | 34,571 0 | 34,571 | Form 4 |
FBB Associates Director 10% Owner | 2012-06-18 17:33:56 | 33,410 0 | 33,410 | Form 3 |
BIENAIME JEAN JACQUES Director | 2024-06-14 12:17:21 | 30,840 0 | 30,840 | Form 4 |
Denton Sheila A. EVP & General Counsel | 2024-10-04 12:39:55 | 30,343 0 | 30,343 | Form 4 |
FOUSE JACQUALYN A Director | 2024-06-14 12:16:49 | 29,325 0 | 29,325 | Form 4 |
Heeson Lee EVP, Head of Incyte Intl | 2024-10-03 13:28:08 | 26,447 0 | 26,447 | Form 4 |
Tray Thomas Principal Accounting Officer | 2024-09-16 13:25:13 | 24,443 0 | 24,443 | Form 4 |
High Katherine A Director | 2024-06-14 12:16:19 | 23,340 0 | 23,340 | Form 4 |
SCHRECK PATRICIA A EVP, General Counsel | 2011-05-11 16:17:53 | 22,276 0 | 22,276 | Form 4 |
BRAWLEY OTIS W Director | 2024-06-14 12:15:43 | 21,251 0 | 21,251 | Form 4 |
Siegel Eric H. EVP, General Counsel | 2017-09-15 16:28:33 | 21,053 0 | 21,053 | Form 4 |
CRAVES FRED B Director | 2005-06-03 09:43:51 | 20,000 0 | 20,000 | Form 4 |
Emmens Matthew Director | 2008-05-22 16:32:43 | 20,000 0 | 20,000 | Form 4 |
NIBLACK JOHN F Director | 2011-05-23 16:38:41 | 20,000 0 | 20,000 | Form 4 |
Levy Richard S EVP, Chief Drug Dev Officer | 2016-01-08 16:37:56 | 19,802 0 | 19,802 | Form 4 |
Clancy Paul J Director | 2024-10-02 13:01:26 | 19,382 0 | 19,382 | Form 4 |
Schaffert Susanne Director | 2024-06-14 12:15:00 | 18,237 0 | 18,237 | Form 4 |
DIXON WENDY L Director | 2022-04-04 16:00:32 | 17,768 0 | 17,768 | Form 4 |
HARRIGAN EDMUND Director | 2024-10-02 13:00:51 | 16,732 0 | 16,732 | Form 4 |
Trotta Matteo EVP, GM, Dermatology US | 2024-07-17 12:28:41 | 16,395 0 | 16,395 | Form 4 |
Chardonnet Laurent Vice President and Treasurer | 2015-04-01 16:27:38 | 15,129 0 | 15,129 | Form 4 |
FBB2 LLC Director 10% Owner | 2012-06-18 17:35:48 | 15,110 0 | 15,110 | Form 3 |
Friedman Steven M. EVP, Biology & Preclinical Dev | 2010-05-20 16:11:55 | 15,000 0 | 15,000 | Form 4 |
GRYSKA DAVID W Executive Vice President, CFO | 2018-07-18 16:12:41 | 10,235 0 | 10,235 | Form 4 |
Trower Paul Principal Accounting Officer | 2022-01-21 16:37:50 | 3,250 0 | 3,250 | Form 4 |
TISCH BONNIE J 10% Owner | 2004-01-16 16:57:59 | 0 0 | 0 | Form 4 |
PLATINUM ASSET MANAGEMENT LTD 10% Owner | 2009-02-10 18:56:09 | 0 0 | 0 | Form 13G |
DAMIAL FOUNDATION INC 10% Owner | 2004-02-13 19:51:28 | 0 0 | 0 | Form 4 |